Enterprise Value to EBITDA Ratio: Simulations Plus, Inc. (SLP)
Serving as the primary valuation tool, this Simulations Plus, Inc. (SLP) price chart demonstrates a metric of 18.05, which correlates with the recruitment of rare bioinformatics programmers for digital drug design. The brand's impeccable authority among regulators confirms its status as a technological leader. Business stability is ensured by the development of critical software in the US, which accelerates the commercialization of new medications by global corporations.
Analytical breakdowns for simulations-plus.com (SLP)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- business book valuation details:
- issuer credit burden and liquidity indicators:
Total Debt to Equity Ratio Simulations Plus, Inc.|SLP - Long-Term Loans to Capital Ratio|Short-Term Debt to Capital Simulations Plus|SLP - Company Total Debt Obligations|Debt to Book Capitalization Ratio Simulations Plus Inc.|SLP - Long-Term Debt|Company Short-Term Debt Simulations Plus|Quick Liquidity simulations-plus.com
- business earnings and investment ratios data:
SLP - Net Financial Result|Future Profit Simulations Plus, Inc.|SLP - Company Value to Net Income|Future Price to Earnings Simulations Plus, Inc.|SLP - Market Cap to Earnings and Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Simulations Plus Inc.|SLP - Profit before payment of interest, taxes and amortization|Net earnings per share for the last 12 months Simulations Plus|SLP - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months simulations-plus.com|SLP - Expected net earnings per share growth this year|Expected earnings per share growth for next year Simulations Plus, Inc.
Comprehensive company analysis:SLP (Simulations Plus Corp)
EV/EBITDA assesses the business value, including net debt, relative to operating profit before depreciation and amortization. By analyzing the historical EV/EBITDA trajectory, an investor determines the degree of asset overvaluation, excluding the impact of tax burdens and financing structures. The indicator's dynamics are sensitive to changes in margins and borrowing volumes. This is critical for Simulations Plus, Inc. (SLP), as large-scale R&D investments in AI modeling directly impact capital value and operational efficiency.
Competitor analysis
Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Veeva Systems Inc VEEV|DOCS - Enterprise Value to EBITDA Ratio|HQY: Enterprise Value to EBITDA Ratio|WAY - EV/EBITDA Multiple|CorVel (CRVL) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|PRVA (Privia Health Group, Inc.) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HURN (Huron Consulting) - EV/EBITDA Multiple|EV/EBITDA Multiple Certara Software|Enterprise Value to EBITDA Ratio OMCL (Omnicell, Inc.)|Enterprise Value to Operating Income Before Depreciation Ratio GDRX|EV/EBITDA Multiple SDGR (Schrödinger)|Total Company Value to Operating Income Before Depreciation Ratio Phreesia Inc (PHR)|OMDA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to EBITDA Evolent Corp|HealthStream, Inc. (HSTM) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation DH|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Consensus Cloud Solutions, Inc.|agilon health, inc. (AGL) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio ABSI (Absci Corp.)|SY (So-Young Corp) - Business Value to Operating Income Before Depreciation|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization National Research NRC|SPOK (spok.com) - Company Value to Operating Income Before Depreciation Ratio|OPRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|TBRG: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SOPH (sophiagenetics.com) - Enterprise Value to EBITDA Ratio|Health Catalyst Inc (HCAT) - EV/EBITDA Multiple|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization CareCloud Inc.|researchsolutions.com (RSSS) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to EBITDA Ratio DLHC (DLH Holdings Corp.)|ONMD (onemednet.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple SCNX (Scienture Holdings Inc.)|Total Company Value to Operating Income Before Depreciation Ratio Healthcare Triangle Corporation (HCTI)|ISPC - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|BFRG (Bullfrog AI Holdings) - Enterprise Value to Operating Income Before Depreciation|WORX: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio MSP Recovery Inc.|Enterprise Value to EBITDA Ratio ICCT|TRxADE Health Corp (MEDS) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Orgenesis Inc. (ORGS)|Total Company Value to Operating Income Before Depreciation Ratio r1rcm.com|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Sharecare SHCR|Streamline Health Solutions, Inc. - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|SYRA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio AMEH|MODN: EV/EBITDA Multiple|NXGN - Total Company Value to Operating Income Before Depreciation Ratio
